Journal of Community Medicine & Health Education
Open 91桃色
Like us on:
organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open 91桃色 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open 91桃色 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Citations : 5447
Indexed In
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Genamics JournalSeek
- SafetyLit
- RefSeek
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Journal of Community Medicine & Health Education : Citations & Metrics Report
Articles published in Journal of Community Medicine & Health Education have been cited by esteemed scholars and scientists all around the world. Journal of Community Medicine & Health Education has got h-index 31, which means every article in Journal of Community Medicine & Health Education has got 31 average citations.
Following are the list of articles that have cited the articles published in Journal of Community Medicine & Health Education.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
Total published articles |
39 | 71 | 63 | 35 | 33 | 57 | 85 | 108 |
Conference proceedings |
5 | 23 | 0 | 0 | 44 | 246 | 119 | 155 |
Citations received as per Google Scholar, other indexing platforms and portals |
110 | 521 | 535 | 550 | 513 | 416 | 342 | 306 |
| Journal total citations count | 5447 |
| Journal impact factor | 9.18 |
| Journal 5 years impact factor | 10.47 |
| Journal cite score | 11.45 |
| Journal h-index | 31 |
| Journal h-index since 2019 | 25 |
 |
Primary care perspectives on implementation of clinical trial recruitment |
| | | | |
|
Academic cancer center phase i program development |
| | | | |
|
Strategies for ensuring diversity, inclusion, and meaningful participation in clinical trials: proceedings of a workshop |
| | | | |
|
Commentary: clinician and researcher contributions to disparities in racial and ethnic minority participation in human subjects research |
| | | | |
|
Empowering Latina breast cancer patients to make informed decisions about clinical trials: a pilot study |
| | | | |
|
Adaptation of a Cancer clinical trials education program for African American and Latina/o community members |
| | | | |
|
Adolescent angst: enrollment on clinical trials |
| | | | |
|
Prevalence, Risk Factors and Morbidity Profile of Schistosoma Infection Among Adults in the Taabo Health and Demographic Surveillance System, South-central C脙麓te d芒聙聶Ivoire |
| | | | |
|
Embedding clinical interventions into observational studies |
| | | | |
|
Barriers to accrual and enrollment in brain tumor trials |
| | | | |
|
Attitudes and Perceptions on the Agricultural Use of HumanExcreta and Human Excreta Derived Materials: A Scoping Review |
| | | | |
|
Challenges facing early phase trials sponsored by the National Cancer Institute: an analysis of corrective action plans to improve accrual |
| | | | |
|
Promoting factors and barriers to participation in early phase clinical trials: patients perspectives |
| View at Publisher | | | |
|
Socio-Demographic Factors Affecting Knowledge, Attitude and Practice towards Blood Donation among University Students in Lahore, Pakistan |
| | | | |
|
Frequency of Regular Voluntary Blood Donors and Factors Associated with Blood Donation in Karachi, Pakistan |
| | | | |
|
Evaluation of Factors affecting voluntary blood donation in South-South Nigeria: Focus on Akwa Ibom State |
| | | | |
|
Adverse Reactions In Whole Blood Donors: A Population Based Statistical-epidemiological Study |
| | | | |
|
Clinical Governance to Enhance User Involvement in Care: A Canadian Multiple Case Study in Mental Health |
| | | | |
|
Diversifying Clinical Research Participants: The Potential Role of Health Information Technologies and Online Strategies |
| | | | |
|
Adverse Reactions in Whole Blood Donors |
| | | | |
